Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...

There's a growing body of evidence that gold nanoparticles can offer significant, targeted weight loss that focuses on fat ...

The new atlas shows the types of cells in fat tissue and their functions but doesn’t clarify if the differences cause ...

A new AP-NORC poll reveals that while most Americans support weight-loss drugs like Ozempic and Wegovy for adults with obesity, they are divided on their use for teens. About half of adults favor ...

In a 42-page article, entitled "Definition and diagnostic criteria of clinical obesity," published in The Lancet: Diabetes & Endocrinology, 56 global experts have just come up with some answers to ...

More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs like Ozempic, Wegovy and other brands if they are struggling with obesity or have a health ...

About Half of Americans Approve of Using Weight-Loss Drugs to Treat Obesity, AP-NORC Poll Finds More U.S. adults believe it is a good thing than a bad thing for adults to use weight-loss drugs ...

MariTide, Amgen's candidate for obesity treatment, has emerged as a focal point for investors. Phase II topline results are expected in late 2024, with analysts anticipating data that could ...